BNP Paribas Financial Markets
BCAB

BNP Paribas Financial Markets’s BIOATLA INC BCAB Stock Holding History

BNP Paribas Financial Markets’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29 Sell
7
-2
-22% -$8 ﹤0.01% 5844
2026
Q1 		$76 Hold
9
– – ﹤0.01% 5697
2025
Q4 		$268 Hold
9
– – ﹤0.01% 5541
2025
Q3 		$325 Hold
9
– – ﹤0.01% 5342
2025
Q2 		$187 Hold
9
– – ﹤0.01% 5288
2025
Q1 		$164 Sell
9
-8
-47% -$171 ﹤0.01% 5225
2024
Q4 		$507 Buy
+17
New +$1.43K ﹤0.01% 5169
2022
Q4 		– Sell
-326
Closed -$125K – 4104
2022
Q3 		$125K Buy
+326
New +$107K ﹤0.01% 3679

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BNP Paribas Financial Markets's BCAB Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its BIOATLA INC (BCAB) stake by 22% in Q2 2026, selling an estimated $8 and leaving 7 shares worth $29. The position accounts for ﹤0.01% of the portfolio, ranked #5844.

BNP Paribas Financial Markets first reported a position in BCAB in Q3 2022 and has held it in 8 quarters since. The position peaked at $125K in Q3 2022. 21 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.

  • BNP Paribas Financial Markets held 7 shares of BIOATLA INC worth $29 as of Q2 2026.
  • BNP Paribas Financial Markets sold 2 BIOATLA INC shares in Q2 2026, an estimated $8.
  • BIOATLA INC made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5844 holding.
  • BNP Paribas Financial Markets first reported a position in BIOATLA INC in Q3 2022 and has held it in 8 quarters since.
  • BNP Paribas Financial Markets's BIOATLA INC position peaked at $125K in Q3 2022.
  • 21 funds tracked by Wall St. Rank held BIOATLA INC as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.